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Abstract
Background: Proteins of the C-terminal binding protein (CtBP) family, CtBP1 and CtBP2 are
closely related transcriptional regulators that are coded by two different gene loci in the vertebrate
genomes. They perform redundant and unique functions during animal development. CtBP proteins
mediate their transcriptional function through interaction with various DNA-binding repressors
that contain PLDLS-like motifs and chromatin modifying enzymes, such as class I histone
deacetylases (HDAC) that do not contain such motifs. The N-terminal region of CtBP1/2 forms a
hydrophobic cleft and is involved in interaction with both PLDLS-containing factors and non-PLDLS
factors. CtBP proteins function as dimers to mediate transcriptional repression and dimerization is
modulated by specific binding to NAD/NADH.
Results: In this study, we have investigated the role of dimerization of CtBP2 in recruitment of
PLDLS-motif cofactors and non-PLDLS cofactors. Our results indicate that mutations in CtBP2 that
interfere with dimerization abolish CtBP2 interaction with most cellular factors, except the PLDLS-
motif factor zinc-finger E-box binding homeobox (ZEB) and the non-PLDLS factor HDAC2. Unlike
most PLDLS-containing CtBP-binding proteins, ZEB contains three PLDLS-like motifs and all three
contribute to the interaction with the CtBP2 monomer. Despite the ability to interact with ZEB
and HDAC, the CtBP2 monomer fails to mediate ZEB-dependent transcriptional repression. The
lack of repression activity of the CtBP2 monomer is correlated with the competition between ZEB
and HDAC for interaction with the CtBP2 monomer.
Conclusion: These results suggest a competition between the canonical PLDLS-motif factors such
as E1A and non-PLDLS factor HDAC for interaction with CtBP. They also indicate that the affinity
for the CtBP monomer may be determined by the number as well as amino acid sequence
compositions of the PLDLS-like motifs. Our results are consistent with a model that the CtBP2
dimer may interact with a PLDLS-containing repressor through one monomer and recruit HDAC
and other chromatin modifying enzymes through the second monomer in the CtBP2 dimer.
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Background
The adenovirus E1A C-terminal binding protein (CtBP)
was identified as a cellular protein that specifically binds
with the PLDLS-motif in E1A and regulates the transform-
ing activity of E1A [1-3]. Subsequent studies have shown
that CtBP is an evolutionarily conserved transcriptional
co-repressor that is utilized by a variety of vertebrate and
invertebrate transcriptional repressors [4]. CtBP1/2 regu-
late expression of genes that control cell differentiation
[5], proliferation [6-8] and apoptosis [9], with critical
consequences on oncogenesis [10].
The CtBP2 locus codes for three splice variants - CtBP2-L
(referred to here as CtBP2), CtBP2-S and Ribeye. CtBP2-L
is localized in the nucleus while CtBP2-S and Ribeye that
lack a unique N-terminal region (NTR) present in CtBP2-
L are cytosolic [11-14]. The CtBP2 NTR is acetylated by
p300 [11] and this modification is linked to the subcellu-
lar localization of CtBP2. CtBP1 which lacks such a
domain is believed to localize in the nucleus by alternate
mechanisms including heterodimerization with CtBP2-L
and interaction with nuclear transcription factors [12,13].
Structural studies have revealed that CtBP1 is a dimer and
the structure is substantially similar to that of 2-hydroxy
acid dehydrogenases [15-17]. CtBP2 also has a similar
structure (Pelka et al., Protein Data Bank, ID 2OME). The
N-terminal region and C-terminal region of CtBP form a
hydrophobic cleft to interact with cofactors that contain
motifs similar to the canonical CtBP-binding motif,
PLDLS present in adenovirus E1A. In addition to the core
PLDLS motif, adjoining sequences may also influence the
affinity of interaction [18].
In vitro studies have shown that dimerization of CtBP1 is
required for interaction with E1A [19]. NAD(H)-mediated
dimerization has been reported to enhance the transcrip-
tional repression activity of CtBP [20,21]. However, it is
unclear whether the CtBP monomer can interact with
PLDLS-containing factors in vivo and mediate transcrip-
tional repression. Although CtBP1 mutants deficient in
dimerization are defective in transcriptional repression, it
is difficult to ascribe this lack of activity to co-factor
recruitment since such mutants of CtBP1 are deficient in
nuclear localization [22].
Transcriptional repression by CtBP proteins appears to be
dependent on simultaneous interaction of CtBP with both
a DNA-binding repressor and a chromatin modifying
enzymes, such as HDAC [23]. Importantly, the cleft
region of CtBP1 appears to be involved in interaction of
both PLDLS-motif factors and non-PLDLS factors [22].
While the PLDLS-dependent interaction between CtBP
and repressors has been well-characterized, the interac-
tion between CtBP and HDAC remains unclear. Since
CtBPs are dimers, the presence of two different cleft
regions in the dimer would complicate the analysis of
interaction of these factors with the cleft region. Here, we
have used a monomeric mutant of CtBP2 that is capable
of nuclear localization under the control of the cognate
nuclear localization signal [12,13,24]. We have discov-
ered that the CtBP2 monomer can interact with a major
CtBP-dependent repressor ZEB as well as HDAC and that
the interaction of the two factors with the CtBP2 mono-
mer was mutually exclusive. These results have led us to
formulate a model by which the CtBP dimer could assem-
ble repression complexes by simultaneous interaction
with a PLDLS-motif factor and a non-PLDLS factor.
Methods
Cell culture, transfection, immunofluorescent staining, and 
luciferase assays
HeLa, 293, MCF7 and CtBP1/2 double knock-out MEF90
cells were cultured in DMEM supplemented with 10%
fetal bovine serum and penicillin/streptomycin. Transfec-
tion reagent jetPEI was used for transient transfection for
luciferase assay, and Lipofectamine 2000 was used for
transfection for co-immunoprecipitation and immun-
ofluorescence analyses as previously described [11]. For
luciferase assays, cells were transfected in 24-well plates in
duplicates. Average luciferase activity was plotted, with
the control luciferase activity normalized to 1.0. Average
deviation was plotted as the error bar. For co-immunopre-
cipitation analysis, cells were transfected in 100 mm
dishes, and cell lysates were immunoprecipitated with the
Flag antibody beads (Sigma). When the HBH tag (His6-
biotinylation-His6) was used, transfected cells were
treated with 5 μM biotin for the duration of transfection,
and immunoprecipitation was performed with the
streptavidin-agarose beads (Pierce). Immunofluorescence
analysis was performed with the Cy3-conjugated Flag
antibody (Sigma).
DSS cross-linking
Cells in 12-well plates were incubated with 5 mM Dissuc-
cinimidyl suberate (DSS) (Pierce) in the culture medium
for 30 min. After washing with PBS, cells were lysed with
200 μl of 2× SDS sample loading buffer and examined by
western blots as described in the text.
Plasmid constructs
The ZEB [GenBank:NM_030751] region coding for aa #680-
780 containing the PLDLS-like motifs was PCR-amplified
with primer N309 (ACATGCGGATCCCTCGAGCCTTTGAA-
GATGACTAACTCCCCA) and N297 (AGCTACGAATTCT-
TAGTCCTTTTGTGGCTCCTTTTTTGCG), digested with
BamHI/EcoRI, and cloned into the vector pGFP-E1A [25] to
generate pGFP-ZEB101. Mutants of ZEB101 were cloned sim-
ilarly by using an overlapping PCR approach [11]. For expres-
sion of GST-ZEB101, ZEB101 region was transferred from
pGFP-ZEB101 to a pGST vector at the XhoI/EcoRI sites.BMC Molecular Biology 2009, 10:89 http://www.biomedcentral.com/1471-2199/10/89
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Mutants of ZEB101 were transferred to the GST vector by the
same approach. RR-CtBP2 and GG-CtBP2 mutants were gen-
erated based on the pFH-CtBP2 construct [11] using the
Quick-Change kit (Stratagene). The primers for RR-CtBP2
(R147L/R169L) were #7065 (CCATCTGCCACATCCTCAAC-
CTGTACGCCA GGAACACGTGGCTGTACCAGGCAC
TGCGG) and #7067 (GGCACGCGGGTTCAGAGCGT-
GGAGCAGAT CCTTGAGGTGGCCTCGGGAGCGGCCCG-
CATC). The primer for GG-CtBP2 (G189A/G192A) was
#7063 (GGCCCGCATCCGTGGGGAGACGCTGGGCCTCA
TTGGCTTTGCTCGCACGGCTCAGGCGGTTGCAGTTCGAG
CCAAGGCC). Other CtBP constructs were described earlier
[11,25].
GST pull-out assay
GST fusion constructs were induced with 1 mM IPTG for
2 h for expression of GST fusion proteins. Lysates contain-
ing the desired GST fusion proteins were loaded onto glu-
tathione-agarose beads in the binding buffer containing
25 mM Tris-HCl (pH7.5), 0.25 M NaCl, 0.5% Triton X-
100, 0.5 mM DTT, 0.1 mM PMSF, and the protease inhib-
itor cocktail (Roche). Subsequently, purified H6-CtBP2
and H6-RR-CtBP2 (~0.1 μg each) were incubated with the
pre-charged glutathione-agarose beads in 200 μl of the
binding buffer for 1 h at 4°C. After washing, bound CtBP2
proteins were examined by Western blot with the CtBP2
monoclonal antibody and the GST fusion proteins exam-
ined by Coomassie blue staining.
Results
Analysis of CtBP2 dimerization
First, we examined the role of various structural elements
of CtBP2 in dimerization using the cross-linking
approach. To validate this approach, we carried out west-
ern-blot analysis of HeLa cells exposed to the cross-linking
agent DSS (Fig. 1A). Higher molecular weight bands that
corresponded to dimers of CtBP1 and CtBP2 were readily
detected while no such dimers were detected in untreated
cells. We noticed a doublet in the position of the endog-
enous CtBP1 and CtBP2 dimers. Although the exact rea-
sons for the formation of such doublets are unknown, it
may be possible that they are due to heterodimerization
of CtBP1 and CtBP2, and/or cross-linking of CtBP to other
cellular proteins. In addition, the high molecular weight
band in lane 3 of Fig. 1A in the absence of DSS could be a
non-specific band or an alternative high order form of
CtBP2 that is resistant to denaturing SDS-PAGE condi-
tions.
To examine the roles of the various CtBP2 domains in
CtBP2 dimerization, Flag-HA-tagged CtBP2 and mutants
were transfected into HeLa cells. After DSS cross-linking,
cell lysates were examined by western blot analysis using
the Flag antibody. As shown (Fig. 1B), deletion of the
unique CtBP2 N-terminal region (NTR) did not affect the
Analysis of dimerization of CtBP2 and its mutants Figure 1
Analysis of dimerization of CtBP2 and its mutants. A, 
Dimerization of endogenous CtBP proteins. HeLa cells were 
treated with DSS and Western blots performed with CtBP1 
and CtBP2 antibodies (Pharmingen). B, Dimerization of tran-
siently expressed CtBP proteins. Various Flag-HA-tagged 
CtBP constructs were transfected into HeLa cells. One day 
after transfection, cells were treated with DSS and cell 
lysates were examined by Western blot analysis using the 
Flag antibody. C, Dimerization defect of RR-CtBP2 and GG-
CtBP2. CtBP2-HBH, RR-CtBP2-HBH, or GG-CtBP2-HBH 
was co-transfected with the Flag-HA-tagged version in indi-
cated combinations. Biotin (5 μM) was added to cells after 
addition of DNA precipitates. After immunoprecipitation 
with the streptavidin (SA) agarose beads, bound proteins 
were analyzed by western blot with a CtBP2 antibody to 
detect FH-CtBP2, or with the streptavidin-HRP conjugate to 
detect CtBP2-HBH proteins.
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extent of dimerization, but severely reduced the ability of
CtBP2 to form higher order forms (compare lanes 2 with
3). Mutations R147L/R169L (mutant RR) corresponding
to the critical residues in the predicted dimerization inter-
face of CtBP1 [15,22] severely reduced dimer formation as
well as other higher order forms of CtBP2 (lane 4).
Despite the reported effects of NAD(H)-binding on CtBP1
dimerization, a mutation in the NAD(H)-binding motif
of CtBP2 (G189A/G192A, mutant GG) did not affect
CtBP2 dimerization by this analysis (lane 5). Similarly, a
mutation within the PLDLS-binding cleft (A58E) that
severely reduces interaction with various PLDLS-motif fac-
tors also did not affect dimerization.
To determine whether the RR-CtBP2 and GG-CtBP2
mutants were capable of forming dimers under normal
(without cross-linking) conditions, HeLa cells were co-
transfected with Flag-HA tagged CtBP2 or various
mutants, and their corresponding versions with a C-termi-
nal HBH tag. The HBH tag contains a biotinylation signal
sequence sandwiched between two (His)6 tags [26]. Cell
lysates were adsorbed with the streptavidin-agarose affin-
ity beads, and the precipitated proteins examined by west-
ern blots as indicated. As shown in Fig. 1C, wt CtBP2-
HBH dimerized efficiently with the wt FH-CtBP2 (lane 3),
whereas the streptavidin-agarose beads did not pull out
FH-CtBP2 alone (lane 4). The RR-CtBP2-HBH mutant did
not dimerize with FH-RR-CtBP2 (lane 2). Interestingly, by
this approach GG-CtBP2-HBH was found to form a dimer
with FH-GG-CtBP2 (lane 1), but at a greatly reduced level
compared to the wt CtBP2 (lane 3). Thus, the RR-CtBP2
mutant may have a reduced level of dimerization which is
only detectible under cross-linking conditions. In con-
trast, the NAD(H)-binding mutant GG-CtBP2 remains
capable of forming a dimer, which appears to be less sta-
ble under co-immunoprecipitation conditions and could
be stabilized by cross-linking with DSS (Fig. 1B).
Co-factor recruitment by monomeric CtBP2
To examine the effects of CtBP2 dimerization and
NAD(H)-binding on interaction with cellular and viral co-
factors, Flag-HA-tagged CtBP2 and the RR-CtBP2 and GG-
CtBP2 mutants were transfected into 293 cells, which
express endogenous E1A, and CtBP2 complexes were
immunoprecipitated from the cell lysates with the Flag
antibody. Western blot analysis of the CtBP2 complexes
showed that the dimerization mutant, RR-CtBP2 (Fig. 2A,
lane 3), and the mutant in the NAD(H)-binding motif,
GG-CtBP2 (lane 4), bound to ZEB and HDAC2 well.
However, binding of mutant RR-CtBP2 to other factors
was defective. In contrast, GG-CtBP2 (lane 4) bound to
other co-factors much less efficiently than the wt CtBP2
but much more efficiently than RR-CtBP2 (lane 3). These
results suggest that dimerization and NAD(H)-binding
are both critical for CtBP2 interaction with co-factors. The
reduced efficiency of GG-CtBP2 binding to most co-fac-
tors appears to be correlated with the reduced stability of
the GG-CtBP2 dimer (Fig. 1).
To compare co-factor binding by CtBP2 and CtBP1, FH-
CtBP1 was also included in the analysis (Fig. 2A, lane 6).
As shown, CtBP1 bound to p300 and E1A more efficiently
than CtBP2, whereas CtBP2 bound to HDAC2 more effi-
ciently than CtBP1. Interestingly, deletion of the CtBP2 N-
terminal domain (lane 5) rendered CtBP2 to behave sim-
ilarly to CtBP1. Thus, the unique N-terminal region (NTR)
of CtBP2 appears to regulate CtBP2 interaction with co-
factors.
Previous results have shown that the unique CtBP2 NTR
allows CtBP2 to be localized completely in the nucleus
while CtBP1 lacking the NTR is localized in both the cyto-
plasm and the nucleus [11]. To examine the role of dimer-
ization for CtBP2 nuclear localization, Flag-HA-tagged
CtBP2, RR-CtBP2, and GG-CtBP2 were transfected into
HeLa cells, and their subcellular localization detected
with the Flag antibody. As shown in Fig. 2B, while the wt
CtBP2 and GG-CtBP2 were predominantly localized in
the nucleus, RR-CtBP2 had significant cytoplasmic locali-
zation. Previous analysis of a CtBP1 dimerization mutant
suggested that it was localized exclusively in the cyto-
plasm [22]. Thus, it appears that while the dimerization
mutations reduced the efficiency of CtBP2 nuclear locali-
Interaction of co-factors with CtBP2 mutants Figure 2
Interaction of co-factors with CtBP2 mutants. A, 
Western blot analysis of CtBP2 protein complex. Flag-HA 
tagged CtBP proteins were transiently expressed in 293 cells. 
Cell lysates were immunoprecipitated with the Flag antibody 
and western blots performed with the antibodies indicated. 
B, Subcellular localization of CtBP2 wt and mutants. HeLa 
cells were transfected with indicated plasmids and immun-
ofluorescence analysis performed with Cy3-Flag antibody.
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zation, the CtBP2 NTR remains functional in targeting the
RR-CtBP2 mutant to the nucleus.
Dimerization and NAD(H)-binding in CtBP2 repression of 
E-cadherin (E-cad) promoter
Transcriptional repression by CtBP1 and CtBP2 requires
CtBP interaction with both DNA-targeting transcription
repressors, such as ZEB [5,27-29], and enzymes involved
in chromatin modification/remodeling, such as HDAC1/
2 [23]. Since both RR-CtBP2 and GG-CtBP2 interacted
with ZEB well (Fig. 2A), we examined the ability of these
CtBP2 mutants to repress the E-cad promoter. Although
several different repressors have been implicated in
repression of the E-cad promoter, ZEB appears to play a
dominant role [5,11,23]. CtBP2 wt or its mutants were co-
transfected with the E-cad-Luc reporter into the CtBP1/2
double knock-out cell line, MEF90. Luciferase assay
showed that GG-CtBP2 retained significant repression
activity, while RR-CtBP2 had no repression activity (Fig.
3A). Thus, the ability of RR-CtBP2 to interact with ZEB
(Fig. 2A) appears to be insufficient for repression of the E-
cad promoter.
Binding of HDAC and ZEB to the CtBP2 monomer is 
mutually exclusive
We previously reported that CtBP2 repression of E-cad
promoter was dependent on HDACs [11]. Our results in
Fig. 2A indicated efficient interaction of HDAC2 and ZEB
with RR-CtBP2 in co-immunoprecipitation studies. Since
RR-CtBP2 interacts with ZEB but does not repress the E-
cad promoter (Fig. 3A), it is possible that RR-CtBP2 inter-
action with ZEB and with HDAC is mutually exclusive. To
examine this possibility, the ZEB region (aa #680-780),
which contains three candidate PLDLS-like motifs, was
cloned as a fusion construct, GFP-ZEB101. Flag-HA-
tagged CtBP2 or RR-CtBP2 was transfected into HeLa cells
alone or together with GFP-ZEB101. Lysates were immu-
noprecipitated with the Flag antibody and the precipi-
tated proteins analyzed by western blots (Fig. 3B). As
shown, both CtBP2 and RR-CtBP2 bound to GFP-ZEB101
as expected (lanes 3 and 5, first panel from top). Control
Transcriptional repression by CtBP2 and mutants and competition between HDAC and ZEB for RR-CtBP2 binding Figure 3
Transcriptional repression by CtBP2 and mutants and competition between HDAC and ZEB for RR-CtBP2 
binding. A, Repression of E-cad promoter by CtBP2 and mutants. CtBP1/2 double knock-out cell line MEF90 cells were co-
transfected with pE-cad-Luc, phRL-tk (for internal control), and various CtBP2 constructs. Dual luciferase assay was performed 
as described [11]. Lysates were examined for CtBP expression by western blot with the CtBP2 antibody (lower panel). B, 
Interaction of wt CtBP2 and RR-CtBP2 with endogenous ZEB and HDAC2 in the presence of GFP-ZEB101. HeLa cells were 
co-transfected with CtBP2 and GFP-ZEB101. Cell lysates were immunoprecipitated with the Flag antibody beads and precipi-
tated proteins examined by western blots as indicated. Both CtBP proteins and GFP fusion proteins carry an HA tag and are 
recognized by the HA antibody. C, Competition between GFP-ZEB101 and HDAC2 for binding to RR-CtBP2. HeLa cells were 
co-transfected with CtBP2 and increasing amounts of GFP-ZEB101. Co-IP and western blot analyses were performed as in B.
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co-transfection of RR-CtBP2 with GFP-Cter, which
expresses a GFP fusion protein containing the E1A C-ter-
minal region encompassing the PLDLS motif [30] showed
that RR-CtBP2 bound to GFP-Cter much less efficiently
(lane 6, first panel), consistent with the observation that
RR-CtBP2 was defective in binding to cellular endogenous
E1A in 293 cells (Fig. 2A). Interaction of CtBP2 or RR-
CtBP2 with GFP-ZEB101 resulted in inhibition of interac-
tion with the cellular endogenous ZEB (lanes 3 and 5, sec-
ond panel), but did not affect CtBP2 interaction with
CoREST (third panel). RR-CtBP2 binding to HDAC2 was
severely competed by GFP-ZEB101 (lane 5, fourth panel),
and was competed to a lesser extent by GFP-Cter (lane 6),
consistent with the lower efficiency of RR-CtBP2 binding
to GFP-Cter. CtBP2 wt binding to HDAC2 was competed
to some extent by GFP-ZEB101 (lane 3). However, CtBP2
retained a higher level of HDAC2 binding than RR-CtBP2
in the presence of GFP-ZEB101 (compare lanes 3 and 5).
To substantiate the conclusion that ZEB and HDAC2
bound to RR-CtBP2 competitively, RR-CtBP2 was co-
transfected with increasing amounts of GFP-ZEB101 into
HeLa cells and co-immunoprecipitation analysis was
again performed (Fig. 3C). As shown, with increasing
amounts of GFP-ZEB101, binding of endogenous ZEB
and HDAC2 to RR-CtBP2 was progressively reduced.
Thus, the competition between ZEB and HDAC2 binding
to RR-CtBP2 may be partly accountable for the defective
transcriptional repression of the E-cad promoter by RR-
CtBP2 (Fig. 3A).
Interaction of ZEB with the CtBP2 monomer requires 
multiple PLDLS-like motifs
The near normal interaction between RR-CtBP2 and ZEB
was in sharp contrast to the defective interaction between
RR-CtBP2 and E1A (Fig. 2A and Fig. 3B). Within the CtBP-
interaction domain of ZEB, there are three PLDLS-like
motifs (Fig. 4A) - a central PLDLS motif, and a PLNLS
motif on both sides. The middle motif is identical to the
canonical CtBP-binding motif of E1A [31]. To directly
examine the roles of the individual PLDLS-like motifs in
interaction with wt CtBP2 and RR-CtBP2, ZEB101 region
was expressed as a GST-ZEB101 fusion protein. Mutants
of GST-ZEB101 were constructed as shown in Fig. 4A, to
incorporate mutations in the PLDLS-like motifs. The
DLm2 mutant contains DL→AS mutations in the central
PLDLS motif, the PLm1/3 mutant contains PL→AS muta-
tions in the two PLNLS motifs, and the PLm1-3 mutant
contains mutations in all three motifs.
GST-ZEB101 and GST-E1A were first used for in vitro pull-
out assays to examine their binding to H6-tagged wt
CtBP2 and RR-CtBP2. As shown in Fig. 4B, while GST-
ZEB101 bound to both wt CtBP2 and RR-CtBP2 efficiently
Roles of PLDLS-like motifs of ZEB in interaction with CtBP2  and RR-CtBP2 Figure 4
Roles of PLDLS-like motifs of ZEB in interaction with 
CtBP2 and RR-CtBP2. A, Diagram of constructs. Num-
bers denote the amino acid residue number in the full-length 
ZEB1. B, Interaction of CtBP2 and RR-CtBP2 with GST-
ZEB101 and GST-E1A. GST-ZEB101, GST-E1A, and GST-
E1A-C* (with a DL→AS mutation in PLDLS motif) were 
charged to glutathione beads and then incubated with puri-
fied H6-CtBP2 or H6-RR-CtBP2. Bound CtBP2 was exam-
ined by western blot with the CtBP2 antibody and GST-
fusion proteins visualized by Coomassie blue. Input (lanes 1 
and 2) represents 5% of input proteins. C, Interaction of 
CtBP2 and RR-CtBP2 with mutants of GST-ZEB101. Condi-
tions were the same as in B, except that Input (lane 1) repre-
sent 10% of input proteins. Bottom panel: Coomassie blue-
stained GST-fusion proteins for the binding assays involving 
H6-CtBP2 (top panel). GST-fusion proteins for the binding of 
H6-RR-CtBP2 were the same (not shown).
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(compare lanes 3 and 6), GST-E1A only bound to wt
CtBP2 efficiently (lane 4) but not to RR-CtBP2 (lane 7).
Neither wt CtBP2 nor RR-CtBP2 interacted with the GFP-
E1A-C* mutant (lanes 5 and 8), which carried a DL→AS
mutation within the PLDLS motif. These results are con-
sistent with the observation in vivo that ZEB bound to RR-
CtBP2 at near normal levels, whereas E1A did not bind to
RR-CtBP2 (Fig. 2A). Thus, the CtBP2 monomer appears to
preferentially interact with ZEB both in vivo and in vitro.
GST-ZEB101 mutants with mutations in various PLDLS-
like motifs were also analyzed for their interaction with
H6-CtBP2 and H6-RR-CtBP2 (Fig. 4C). For this analysis,
comparable amounts of H6-CtBP2 and H6-RR-CtBP2
were used (as indicated in lane 1 of top and middle pan-
els). In all lanes bound H6-CtBP2 and H6-RR-CtBP2 were
examined on the same western blot, and were arranged as
the top (for H6-CtBP2) and middle (for H6-RR-CtBP2)
panels for comparison. As shown, despite a small reduc-
tion in interaction between H6-CtBP2 and ZEB101-DLm2
(lane 3, top panel), H6-CtBP2 (top panel) interacted effi-
ciently with the wt ZEB101 (lane 2), as well as the two
mutants (lanes 3 and 4). In contrast, H6-RR-CtBP2 (mid-
dle panel) bound to GST-ZEB101 and mutants less effi-
ciently than H6-CtBP2 (top panel). In particular, H6-RR-
CtBP2 bound to GST-ZEB101 (middle panel, lane 2)
much better than the ZEB101-DLm2 mutant (middle
panel, lane 3). The ZEB101-PLm1/3 mutant (lane 4)
bound to RR-CtBP2 only slightly less efficiently than the
wt ZEB101 (lane 2). As expected, mutation of all three
PLDLS-like motifs rendered ZEB101 incapable of interac-
tion with both the wt CtBP2 (top panel, lane 5) and the
RR-CtBP2 mutant (middle panel, lane 5). These results
suggested that all three PLDLS-like motifs in ZEB101 may
contribute to the interaction with RR-CtBP2. Among the
three motifs the central PLDLS motif appears to be most
important.
Nuclear targeting of GFP-ZEB by CtBP2 monomeric 
mutant
We previously reported that CtBP2 promotes nuclear
localization of a cytoplasmically localized E1A mutant
[11]. GFP-ZEB101 was localized throughout the cell in a
diffused pattern (Fig. 5A, top panel), consistent with the
fact that the ZEB sequence does not contain a nuclear
localization signal. Coexpression of GFP-ZEB101 and
CtBP2 wt resulted in nuclear localization of GFP-ZEB101
(Fig. 5B, top panel). Interestingly, co-expression of GFP-
ZEB101 with RR-CtBP2 also resulted in nuclear localiza-
tion of GFP-ZEB101 (Fig. 5C, top panel), despite the
reduced efficiency of nuclear localization for RR-CtBP2
compared to wt CtBP2 (Fig. 2B). It should be noted that
RR-CtBP2 nuclear localization seems to be slightly
enhanced by co-transfection with GFP-ZEB101 (compare
Fig. 5B and 5C with Fig. 2B). It might be possible that
interaction of RR-CtBP2 with a PLDLS-containing partner
Enhancement of nuclear localization of GFP-ZEB101 by RR-CtBP2 Figure 5
Enhancement of nuclear localization of GFP-ZEB101 by RR-CtBP2. GFP-ZEB fusion constructs were co-transfected 
with Flag-HA-tagged CtBP2 or RR-CtBP2. One day after transfection, cells were fixed and stained with Cy3-conjugated Flag 
antibody to visualize CtBP2 and RR-CtBP2. Localization of GFP-ZEB fusion proteins was indicated by the fluorescence of GFP.
+ Vector + CtBP2 + RR-CtBP2 + CtBP2 + RR-CtBP2 + CtBP2
GFP
CtBP
DAPI
ABCDEF
GFP-ZEB101 GFP-DLm2 GFP-PLm1-3BMC Molecular Biology 2009, 10:89 http://www.biomedcentral.com/1471-2199/10/89
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helps stabilize the conformation of RR-CtBP2 to enhance
the nuclear localization of RR-CtBP2. In contrast, the sub-
cellular localization of GFP-ZEB-PLm1-3 was only mar-
ginally changed by co-expression of wt CtBP2 (Fig. 5F),
consistent with the observation that interaction of wt
CtBP2 and RR-CtBP2 with GST-ZEB-PLm1-3 was defective
(Fig. 4C). Although RR-CtBP2 interacted with GST-ZEB-
DLm2 in vitro much more weakly than wt CtBP2 (Fig. 4C),
both wt CtBP2 and RR-CtBP2 enhanced nuclear localiza-
tion of GFP-ZEB-DLm2 (Fig. 5D and 5E) suggesting that
even a weaker interaction between RR-CtBP2 and GFP-
ZEB-DLm2 may be sufficient for enhanced nuclear locali-
zation of GFP-ZEB-DLm2. Thus, both the CtBP2 dimer
and CtBP2 monomer appear to be capable of promoting
the nuclear localization of their interaction partners.
Transcriptional repression by RR-CtBP2 when tethered to 
the promoter by Gal4 fusion
To examine the functional correlation between CtBP2
interaction with GFP-ZEB101 and CtBP2 transcriptional
repression, ZEB101 was expressed as a Gal4-ZEB101
fusion protein. Co-transfection of Gal4-ZEB101 with the
luciferase reporter, G5-MLP-Luc, into MCF7 cells resulted
in transcriptional repression (Fig. 6A). Similarly, Gal4-
ZEB-DLm2 was also active in repression, consistent with
the ability of GST-ZEB-DLm2 to interact with both the
CtBP2 monomer and CtBP2 dimer (Fig. 4). In contrast,
Gal4-ZEB-PLm1-3 did not repress transcription, possibly
due to its defective interaction with CtBP.
When Gal4-ZEB101 was co-transfected with G5-MLP-Luc
into MEF90 cells with CtBP1/2 double knock-out, it did
not repress transcription (Fig. 6B), consistent with the
CtBP deficiency in MEF90 cells. However, co-transfection
of Gal4-ZEB101 with CtBP2 resulted in transcriptional
repression. In contrast, co-transfection of Gal4-ZEB101
with RR-CtBP2 had a much lower transcriptional repres-
sion activity. These results are consistent with the observa-
tion that RR-CtBP2 binding to ZEB and HDAC2 is
mutually exclusive (Fig. 3B and 3C). When Gal4-ZEB-
PLm1-3 was co-transfected with CtBP2, a low level of tran-
scriptional repression was observed. However, the level of
activity was much less compared to that mediated by
Gal4-ZEB101. The transcriptional repression activity
mediated by Gal4-PLm1-3 could be due to a low level of
in vivo interaction between Gal4-PLm1-3 and CtBP2.
Thus, the ability of Gal4-ZEB101 to repress transcription
appears to be correlated with interaction of endogenous
CtBP2 through the PLDLS-like motifs in Gal4-ZEB101.
The ability of CtBP2 and RR-CtBP2 to directly repress tran-
scription was also examined by the Gal4-tethering assay
(Fig. 6C). As shown, both Gal4-CtBP2 and Gal4-RR-
CtBP2 were active in repression of transcription. Thus,
once tethered to the promoter by Gal4, the CtBP2 mono-
HDAC-dependent transcriptional repression by Gal4-RR- CtBP2 Figure 6
HDAC-dependent transcriptional repression by 
Gal4-RR-CtBP2. A, Transcriptional repression by Gal4-
ZEB101. Gal4 fusion constructs were co-transfected into 
MCF7 cells with pG5-Luc and phRL-tk. Dual luciferase assay 
was performed as in Fig. 3A. DBD: Gal4 DNA binding 
domain. B, Failure of RR-CtBP2 to repress transcription 
through Gal4-ZEB101. CtBP1/2 double knockout cells were 
co-transfected with pG5-Luc, phRL-tk, Gal4-ZEB101 and 
CtBP2 or RR-CtBP2. Dual luciferase assay was performed as 
in A. C, HDAC-dependent transcriptional repression by 
Gal4-CtBP2 and Gal4-RR-CtBP2. MEF90 cells were co-trans-
fected with pG5-Luc, phRL-tk, and Gal4-CtBP2 or Gal4-RR-
CtBP2. HDAC inhibitor TSA was added at 0.2 ng/ml during 
transfection. Dual luciferase assay was carried out as in A.
A
B
C
DBD G-ZEB101 G-PLm1-3BMC Molecular Biology 2009, 10:89 http://www.biomedcentral.com/1471-2199/10/89
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mer is capable of transcriptional repression. Importantly,
when the HDAC inhibitor TSA was included during trans-
fection, transcriptional repression by both Gal4-CtBP2
and Gal4-RR-CtBP2 was abolished. Thus, Gal4-tethered
transcriptional repression by CtBP2 and RR-CtBP2
appeared to be mostly mediated by HDAC.
Discussion
The transcriptional repression function of CtBP corepres-
sors appears to depend on simultaneous recruitment of
DNA-binding repressors and chromatin modifying
enzymes by CtBP. CtBP interaction with DNA binding
repressors is usually mediated through PLDLS-like motifs
in the repressors [4,32]. In some cases, it also involves an
auxiliary motif known as the RRT motif present in repres-
sors such as Znf217 [33]. In contrast to our understanding
of the mode of interaction of PLDLS-motif and PLDLS/
RRT motif factors, the mode of interaction of chromatin
modifying enzymatic constituents of the CtBP corepressor
complex remains less well defined. A detailed mutagene-
sis study of CtBP1 has indicated that the PLDLS-binding
cleft of CtBP1 plays a critical role in recruiting these fac-
tors [22]. Certain amino acid substitution mutations
within the cleft region of CtBP1 [22] and CtBP2 [25] affect
interaction with both PLDLS-motif factors and HDAC1/2.
In an earlier study, we have attempted to investigate inter-
action of CtBP cofactors with a monomeric mutant of
CtBP1 [22]. Since CtBP1 monomeric mutants were
excluded from the nucleus, we used a heterologous
(SV40) nuclear localization signal to target such mutants
to the nucleus. The interaction of most cofactors with such
chimeric mutant was substantially increased suggesting
that the observed interaction may not reflect the normal
pattern of interaction possibly due to localization of the
mutant in non-relevant nuclear sub-compartment. Thus,
our present analysis of cofactor interaction with the mon-
omeric CtBP2 targeted to the nucleus via the cognate tar-
geting mechanism appears to reflect the normal pattern of
interaction.
We employed two different CtBP2 mutants, one with
mutations in residues corresponding to residues of CtBP1
implicated in dimerization (RR-CtBP2) and the other in
the conserved NAD(H)-binding motif (GG-CtBP2). Since
no direct structural data is available for these mutants,
potential unintended effects of these mutations on CtBP2
structure may not be excluded. Interestingly, both RR-
CtBP2 and GG-CtBP2 bound to ZEB and HDAC2 to near
normal levels (Fig. 2A). In contrast, GG-CtBP2 binding to
other CtBP2 co-factors was greatly reduced, and RR-CtBP2
binding to these co-factors was mostly defective. These
observations suggest that CtBP2 interaction with certain
cofactors may be less dependent on dimerization or
NAD(H)-binding, and raise the possibility that CtBP2
monomer may have unique functions. It should be noted
that by DSS cross-linking analysis, RR-CtBP2 still retained
a small degree of dimerization (Fig. 1B). The possibility
that the low level of dimerization is required for RR-CtBP2
to interact with ZEB and HDAC2 could not be excluded.
Examination of subcellular localization of CtBP2 and its
mutants revealed that while GG-CtBP2 and wt CtBP2
assumed a predominant nuclear localization pattern, RR-
CtBP2 had significant cytoplasmic localization. Thus,
although NAD(H)-binding does not appear to be critical
for CtBP2 nuclear localization (Fig. 2B), it significantly
affects CtBP2 interaction with co-factors other than ZEB
and HDAC2. The reduced efficiency of RR-CtBP2 nuclear
localization may be partially accountable for the reduced
interaction of RR-CtBP2 with ZEB (Fig. 2A).
The observations with the mutant of CtBP2 in the
NAD(H)-binding motif, GG-CtBP2, revealed important
clues to transcriptional repression by CtBP2. The dimeri-
zation of the GG-CtBP2 mutant was normal as judged by
DSS cross-linking (Fig. 1B). However, by co-immunopre-
cipitation analysis the GG-CtBP2 mutant dimerized at a
greatly reduced efficiency compared to the wt CtBP2 (Fig.
1C). These results seem to be consistent with the hypoth-
esis that NAD(H)-binding induces conformational
changes in CtBP to stabilize CtBP dimerization [21]. In
CtBP1/2 double knock-out MEF90 cells, retrovirally-
expressed GG-CtBP2 had similar activity as the wild type
CtBP2 in E-cad promoter localization and E-cad transcrip-
tional repression, whereas RR-CtBP2 expressed in this
fashion was unstable and could not be analyzed (data not
shown). These results are consistent with the finding that
GG-CtBP2 binding to ZEB and HDAC2 was nearly normal
(Fig. 2A), and GG-CtBP2 remains capable of transcrip-
tional repression in transient reporter assays (Fig. 3A).
Although E-cad transcriptional repression by CtBP2 does
not appear to require NAD(H)-binding by CtBP2, it is
possible that under certain physiological conditions
NAD(H)-binding by CtBP2 becomes important for the
transcriptional repression activity of CtBP2. Importantly,
since GG-CtBP2 binding to co-factors other than ZEB and
HDAC2 was severely reduced, it is expected that CtBP2
regulation of other potential candidate target genes is
more dependent on NAD(H) binding than repression of
E-cad.
Two important results have emanated from our present
study with the monomeric CtBP2 - 1) CtBP2 co-factors
have varying degrees of requirements for CtBP2 dimeriza-
tion and NAD(H)-binding, and 2) the interaction of
HDAC and PLDLS-motif factors with CtBP2 monomer
might be mutually exclusive. The interaction between
CtBP2 monomer and ZEB appears to be dependent on
three PLDLS-like motifs. Mutational analysis of these
motifs in ZEB suggest that the central PLDLS motif is most
critical, while the two flanking PLNLS motifs appear toBMC Molecular Biology 2009, 10:89 http://www.biomedcentral.com/1471-2199/10/89
Page 10 of 12
(page number not for citation purposes)
play auxiliary roles (Fig. 4). It is important to note that the
PLDLS motif in E1A is identical to the central PLDLS motif
of ZEB, and yet the GFP-E1A-Cter fusion protein inter-
acted with the CtBP2 monomer much more weakly than
GFP-ZEB101 (Fig. 3B), suggesting that auxiliary motifs
may contribute to the unique binding activity of ZEB. Our
results on ZEB binding with CtBP2 monomer agrees well
with a previous report on ZEB binding with CtBP1 and
repression assays, where all three sites were found to be
required for efficient CtBP-binding and full repression
activity [28]. Thus, the unique arrangement of the three
PLDLS-like motifs in ZEB appears to contribute to the
ability of ZEB to interact with the CtBP2 monomer. It
seems possible that the two PLNLS motifs in ZEB may
function as low affinity nucleation sites and the central
PLDLS motif may function as the high affinity site for sta-
ble interaction with CtBP2.
It is possible that presence of two or more binding motifs
among the CtBP binding factors may be more prevalent
than previously recognized. For example, the presence of
a PLNLS motif and the RRT motif in Znf217 facilitates
interaction with the CtBP dimer [33]. The possibility that
a similar mode of interaction may be used by Riz, Znf516
[33] and Wiz [22,34] has been pointed out. Our present
study shows that the PLDLS and PLNLS motifs of ZEB are
functionally redundant for interaction with the CtBP2
dimer. Two different divergent PLDLS-related motifs of
EBV EBNA3B have been reported to synergize for binding
with CtBP [35]. More recently a second binding site has
been identified in adenovirus E1A, in addition to the
PLDLS motif [36]. Presence of divergent and functionally
redundant CtBP-binding motifs in transcription factors
may regulate transcription by context-dependent recruit-
ment of CtBP and chromatin modifying enzymes.
Our current analysis of cofactor interaction with the
CtBP2 monomer has revealed new insights into the mech-
anism of the HDAC-dependent repression of the E-cad
promoter by CtBP2. ZEB and HDAC2 appeared to com-
pete for interaction with the CtBP2 monomer since co-
expression of the CtBP2 monomer with GFP-ZEB101
severely hindered HDAC2 interaction with RR-CtBP2
(Fig. 3B and 3C). HDAC2 interaction with RR-CtBP2 was
progressively reduced by increasing amounts of GFP-
ZEB101 (Fig. 3C). This may account for the lack of repres-
sion of the E-cad promoter by the CtBP2 monomer (Fig.
3A). A CtBP2 monomer anchored to the E-cad promoter
through interaction with ZEB may not be able to recruit
repressive enzymes such as HDAC2 to the promoter.
However, anchoring of the CtBP2 monomer onto a pro-
moter through Gal4 fusion rendered the CtBP2 monomer
capable of transcriptional repression (Fig. 6C), consistent
with the conclusion that after Gal4 anchoring of RR-
CtBP2 to the promoter, the CtBP2 monomer remains
capable of recruiting HDAC. Although Gal4 functions as a
dimer, it is expected that the Gal4-RR-CtBP2 "quasi"
dimer is structurally and functionally different from the
natural CtBP2 dimer, and the ability of Gal4-RR-CtBP2 to
repress transcription resides in the ability of RR-CtBP2 to
recruit HDAC.
Our results are consistent with the hypothesis that strong
interaction of PLDLS-motif factors such ZEB with the
CtBP2 monomer may preclude interaction of the CtBP2
monomer with HDAC (Fig. 7A). These results also lend
support to the model of transcriptional repression by
CtBP2 (Fig. 7B), in which CtBP2 normally interacts with a
DNA-bound repressor through one CtBP2 monomer, and
recruits a DNA modifying enzyme, such as HDAC through
the other CtBP2 monomer. In this context, it remains pos-
sible that interaction of one CtBP2 monomer with a
repressor, such as ZEB, may help facilitate recruitment of
HDAC through the other CtBP2 monomer.
Conclusion
1) CtBP2 monomer retains ability to interact with ZEB
but this interaction does not result in transcriptional
repression.
Model for HDAC-dependent transcriptional repression by  CtBP2 Figure 7
Model for HDAC-dependent transcriptional repres-
sion by CtBP2. A, Interaction of HDAC1/2 and ZEB with 
CtBP2 monomer. Based our on results we suggest that 
HDAC1/2 interact with CtBP2 sequences that encompass 
the hydrophobic cleft (PLDLS-binding) region and additional 
regions such as the NTR, while ZEB and other PLDLS-motif 
containing transcription factors interact exclusively with the 
cleft region. Our results suggest that interaction of the 
CtBP2 monomer with HDAC1/2 and the PLDLS-motif fac-
tors is mutually exclusive. B, Transcriptional repression by 
CtBP2. We propose that recruitment of CtBP2 with the 
DNA-bound PLDLS-motif containing repressor via one mon-
omer of the CtBP2 dimer might facilitate recruitment of 
HDAC1/2 via the second CtBP2 monomer.
NTR
Cleft
CtBP2
CtBP2
Repressor
PLDLS-binding
cleft
HDAC1/2
ZEB
CtBP2
NTR
A
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2) CtBP2 monomer interaction with ZEB involves
three PLDLS-like motifs, each of which contributes to
interaction to various extents.
3) A mutant in the NAD(H)-binding motif of CtBP2
seems to interact with ZEB normally and repress E-cad
transcription normally.
4) CtBP2 monomer interaction with ZEB and HDAC
is mutually exclusive.
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